跳至主要内容
临床试验/CTRI/2023/03/050390
CTRI/2023/03/050390尚未招募不适用

The Effect of Preoperative IV Tranexamic acid on intraoperative blood loss in cancer surgeries at a tertiary care centre in South India – A Randomised Controlled Trial

未提供1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年8月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
1. Operative blood loss

研究概览

简要总结

To determine the impact of preoperative administration of tranexamic acid on

1.     Intra-operative blood loss and

2.     transfusion rates

in major oncological surgeries

研究设计

研究类型
Interventional
分配方式
Stratified block randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
10.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • all cancer patients undergoing surgeries for breast gyanecology, Head &neck ,GI, soft tissue sarcoma& others.

排除标准

  • Patients with coagulopathy(activated partial thromboplastin time >50 s or International normalised ratio >1.5, platelets <50 X 109/L), Recent history of acetylsalicylic acid ingestion (< 5 days), Patients on anticoagulation therapy (received heparin within 4 hours or received warfarin 3 days preoperatively), Those with known peripheral vascular disease, Pre-existing renal dysfunction (serum creatinine >1.2 mg/dl), Liver dysfunction, Known allergy to tranexamic acid.

结局指标

主要结局

1. Operative blood loss

时间窗: baseline

2. Blood transfusion rates

时间窗: baseline

次要结局

  • 1.Length of hospital stay(2.Length of stay in ICU)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验